{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:20:08Z","timestamp":1773685208036,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T00:00:00Z","timestamp":1356652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s10067-012-2150-x","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T06:56:47Z","timestamp":1356591407000},"page":"403-407","source":"Crossref","is-referenced-by-count":6,"title":["Valproate-induced hyperammonaemia superimposed upon severe neuropsychiatric lupus: a case report and review of the literature"],"prefix":"10.1007","volume":"32","author":[{"given":"Estee","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"McQueen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,28]]},"reference":[{"key":"2150_CR1","volume-title":"Renal diseases: classification and atlas of glomerular disease","author":"J Churg","year":"1982","unstructured":"Churg J, Sobin LH (1982) Renal diseases: classification and atlas of glomerular disease. Igaku-Shoin, Tokyo"},{"issue":"4","key":"2150_CR2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","author":"American College of Rheumatology (ACR)","year":"1999","unstructured":"American College of Rheumatology (ACR) (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 42(4):599\u2013608","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2150_CR3","first-page":"732","volume":"19","author":"JG Hanly","year":"1992","unstructured":"Hanly JG, Walsh NM, Sangalang V (1992) Brain pathology in systemic lupus erythematosus. J Rheumatol 19(5):732\u2013741","journal-title":"J Rheumatol"},{"key":"2150_CR4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00002281-199609000-00004","volume":"8","author":"G Sterling","year":"1996","unstructured":"Sterling G, West MD (1996) Lupus and the central nervous system. Curr Opin Rheumtol 8:408\u2013414","journal-title":"Curr Opin Rheumtol"},{"issue":"5","key":"2150_CR5","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.berh.2005.04.003","volume":"19","author":"JG Hanly","year":"2005","unstructured":"Hanly JG, Harrison MJ (2005) Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 19(5):799\u2013821","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"2150_CR6","first-page":"985","volume":"30","author":"G Sanna","year":"2005","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ et al (2005) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30(5):985\u2013992","journal-title":"J Rheumatol"},{"key":"2150_CR7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","volume":"7","author":"LA DeGiorgio","year":"2001","unstructured":"DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1189\u20131193","journal-title":"Nat Med"},{"key":"2150_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00313894","volume":"232","author":"R Campostrini","year":"1985","unstructured":"Campostrini R, Zaccara G, Rossi L, Paganini M, Dorigotti A, Zappoli R (1985) Valproate-induced hyperammonaemia in two epileptic identical twins. J Neurol 232:167\u2013168","journal-title":"J Neurol"},{"key":"2150_CR9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0196-0644(05)81955-9","volume":"22","author":"SK Kulick","year":"1993","unstructured":"Kulick SK, Kramer DA (1993) Hyperammonemia secondary to valproic acid as a cause of lethargy in a postictal patient. Ann Emerg Med 22:610\u2013612","journal-title":"Ann Emerg Med"},{"key":"2150_CR10","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/jnnp.64.5.680","volume":"64","author":"M Oechsner","year":"1998","unstructured":"Oechsner M, Steen C, Sturenburg HJ, Kohlschutter A (1998) Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognized ornithine transcarbamylase deficiency. J Neurol Neurosurg Psychiatry 64:680\u2013682","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2150_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.51.1.292","volume":"51","author":"KA Blindauer","year":"1998","unstructured":"Blindauer KA, Harrington G, Morris GL, Ho K (1998) Fulminant progression of demyelinating disease after valproate-induced encephalopathy. Neurology 51:292\u2013295","journal-title":"Neurology"},{"issue":"2","key":"2150_CR12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1528-1157.2002.25001.x","volume":"43","author":"DG Vossler","year":"2002","unstructured":"Vossler DG, Wilensky AJ, Cawthon DF et al (2002) Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy. Epilepsi 43(2):154\u2013159","journal-title":"Epilepsi"},{"issue":"9","key":"2150_CR13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1528-1157.2002.42201.x","volume":"43","author":"S Ziyeh","year":"2002","unstructured":"Ziyeh S, Thiel T, Spreer J, Klisch J, Schumacher M (2002) Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy. Epilepsia 43(9):1101\u20131105","journal-title":"Epilepsia"},{"issue":"4","key":"2150_CR14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajgp.10.4.476","volume":"10","author":"D Feil","year":"2002","unstructured":"Feil D, Chuang K, Sultzer DL (2002) Valproate-induced hyperammonemia as a cause of altered mental status. Am J Geriatr Psychiatr 10(4):476\u2013478","journal-title":"Am J Geriatr Psychiatr"},{"key":"2150_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/pmj.78.919.316-a","volume":"78","author":"M O\u2019Neill","year":"2002","unstructured":"O\u2019Neill M, Dubrey RW, Grocott-Mason RM (2002) Valproate encephalopathy and hyperammonaemia. Postgrad Med J 78:316\u2013318","journal-title":"Postgrad Med J"},{"key":"2150_CR16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1600-0404.2003.00227.x","volume":"109","author":"CM Lokrantz","year":"2004","unstructured":"Lokrantz CM, Eriksson B, Rosen I, Asztely F (2004) Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam. Acta Neurol Scand 109:297\u2013301","journal-title":"Acta Neurol Scand"},{"key":"2150_CR17","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1345\/aph.1E063","volume":"38","author":"L Mallet","year":"2004","unstructured":"Mallet L, Babin S, Morais JA (2004) Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman. Ann Pharmacother 38:1643\u20131647","journal-title":"Ann Pharmacother"},{"key":"2150_CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hup.575","volume":"19","author":"P Latour","year":"2004","unstructured":"Latour P, Biraben A, Polard E et al (2004) Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Hum Psychopharmacol Clin Exp 19:193\u2013203","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"2150_CR19","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1345\/aph.1G167","volume":"39","author":"M Cuturic","year":"2005","unstructured":"Cuturic M, Abramson RK (2005) Acute hyperammonemic coma with chronic valproic acid therapy. Ann Pharmacother 39:2119\u20132123","journal-title":"Ann Pharmacother"},{"key":"2150_CR20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.63.8.1202","volume":"63","author":"JP Soares-Fernandes","year":"2006","unstructured":"Soares-Fernandes JP, Machado A, Ribeiro M, Ferreira C, Figueiredo J, Rocha JF (2006) Hippocampal involvement in valproate-induced acute hyperammonemic encephalopathy. Arch Neurol 63:1202\u20131203","journal-title":"Arch Neurol"},{"issue":"2","key":"2150_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0019-5545.42400","volume":"50","author":"R Pradeep","year":"2008","unstructured":"Pradeep R (2008) Valproate monotherapy induced-delirium due to hyperammonemia: a report of three adult cases with different types of presentation. Indian J Psychiatr 50(2):121\u2013123","journal-title":"Indian J Psychiatr"},{"key":"2150_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.seizure.2006.05.007","volume":"15","author":"T Gerstner","year":"2006","unstructured":"Gerstner T, Buesing D, Longin E et al (2006) Valproic acid induced encephalopathy\u201419 new cases in Germany from 1994 to 2003\u2014a side effect associated to VPA-therapy not only in young children. Seizure 15:443\u2013448","journal-title":"Seizure"},{"issue":"4","key":"2150_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.yebeh.2007.02.013","volume":"10","author":"YB Gomceli","year":"2007","unstructured":"Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE (2007) Different clinical manifestations of hyperammonemic encephalopathy. Epilepsy Behav 10(4):583\u2013587","journal-title":"Epilepsy Behav"},{"key":"2150_CR24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0960327107087799","volume":"26","author":"YC Chan","year":"2007","unstructured":"Chan YC, Tse ML, Lau FL (2007) Two cases of valproic acid poisoning treated with l-carnitine. Hum Exp Toxicol 26:967\u2013969","journal-title":"Hum Exp Toxicol"},{"issue":"5","key":"2150_CR25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.jcp.0000138768.61600.ad","volume":"24","author":"M McCall","year":"2004","unstructured":"McCall M, Bourgeois JA (2004) Valproic acid induced hyperammonaemia: a case report. J Clin Psychopharmacol 24(5):521\u2013526","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"2150_CR26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1373\/clinchem.2010.151225","volume":"57","author":"AS Davison","year":"2011","unstructured":"Davison AS, Milan AM, Roberts NB (2011) The consequences of valproate overdose. Clin Chem 57(9):1223\u20131238","journal-title":"Clin Chem"},{"issue":"4","key":"2150_CR27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.yebeh.2011.05.006","volume":"21","author":"A Gomez-Ibanez","year":"2011","unstructured":"Gomez-Ibanez A, Urrestarazu-Bolumburu E, Viteri-Torres C (2011) Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism. Epilepsy Behav 21(4):480\u2013482","journal-title":"Epilepsy Behav"},{"issue":"9","key":"2150_CR28","first-page":"389","volume":"69","author":"MC Prins","year":"2011","unstructured":"Prins MC, van Meijel JJ (2011) A case of hyperammonaemic encephalopathy due to valproic acid. Neth J Med 69(9):389\u2013391","journal-title":"Neth J Med"},{"issue":"10","key":"2150_CR29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.amjmed.2010.02.029","volume":"123","author":"JN LaBuzetta","year":"2010","unstructured":"LaBuzetta JN, Yao JZ, Bourque DL, Zivin J (2010) Adult nonhepatic hyperammonemia: a case report and differential diagnosis. Am J Med 123(10):885\u2013891","journal-title":"Am J Med"},{"key":"2150_CR30","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ps.49.10.1358","volume":"49","author":"E Eze","year":"1998","unstructured":"Eze E, Workman M, Donley B (1998) Hyperammonemia and coma developed by a woman treated with valproic acid for affective disorder. Psychiatr Serv 49:1358\u20131359","journal-title":"Psychiatr Serv"},{"key":"2150_CR31","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1553-2712.2001.tb01102.x","volume":"8","author":"F Barrueto","year":"2001","unstructured":"Barrueto F, Hack JB (2001) Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy. Acad Emerg Med 8:999\u20131001","journal-title":"Acad Emerg Med"},{"issue":"3","key":"2150_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/JCP.0b013e31817275b6","volume":"28","author":"J Stewart","year":"2008","unstructured":"Stewart J (2008) A case of hyperammonemic encephalopathy after 11\u00a0years of valproate therapy. J Clin Psychopharmcol 28(3):361\u2013362","journal-title":"J Clin Psychopharmcol"},{"key":"2150_CR33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3122\/jabfm.2007.05.070062","volume":"20","author":"J Wadzinski","year":"2007","unstructured":"Wadzinski J, Franks R, Roane D, Bayard M (2007) Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med 20:499\u2013502","journal-title":"J Am Board Fam Med"},{"issue":"8","key":"2150_CR34","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1176\/ajp.154.8.1168","volume":"154","author":"WN Raby","year":"1997","unstructured":"Raby WN (1997) Carnitine for valproic acid-induced hyperammonemia. Am J Psychiatry 154(8):1168\u20131169","journal-title":"Am J Psychiatry"},{"key":"2150_CR35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4088\/JCP.v60n0809g","volume":"60","author":"GP Panikkar","year":"1999","unstructured":"Panikkar GP, Gilman SM (1999) Valproate-induced hyperammonemia in the psychiatric setting: 2 cases. J Clin Psychiatry 60:557\u2013559","journal-title":"J Clin Psychiatry"},{"key":"2150_CR36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2190\/XW8E-Q283-4429-QL71","volume":"33","author":"L Elgudin","year":"2003","unstructured":"Elgudin L, Hall Y, Schubert D (2003) Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report. Int J Psychiatry Med 33:91\u201396","journal-title":"Int J Psychiatry Med"},{"key":"2150_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/appi.psy.49.1.82","volume":"49","author":"AL Eubanks","year":"2008","unstructured":"Eubanks AL, Aguirre B, Bourgeois JA (2008) Severe acute hyperammonemia after brief exposure to valproate. Psychosomatics 49:82\u201383","journal-title":"Psychosomatics"},{"key":"2150_CR38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/00048670902821606","volume":"43","author":"LN Abreu","year":"2009","unstructured":"Abreu LN, Issler C, Lafer B (2009) Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient. Aust N Z J Psychiatr 43:484\u2013485","journal-title":"Aust N Z J Psychiatr"},{"issue":"6","key":"2150_CR39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/0269881109102635","volume":"24","author":"JC Shan","year":"2010","unstructured":"Shan JC, Hsieh MH, Liu CC, Wen CC, Liu CM (2010) Clinical alertness to valproic acid-induced hyperammonemia\u2014two case reports. J Psychopharmacol 24(6):943\u2013945","journal-title":"J Psychopharmacol"},{"issue":"5","key":"2150_CR40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jocn.2010.08.022","volume":"18","author":"J Rupasinghe","year":"2011","unstructured":"Rupasinghe J, Jasinarachchi M (2011) Progressive encephalopathy with cerebral oedema and infarctions associated with valproate and diazepam overdose. J Clin Neurosci 18(5):710\u2013711","journal-title":"J Clin Neurosci"},{"issue":"8","key":"2150_CR41","first-page":"1236","volume":"152","author":"EC Settle Jr","year":"1995","unstructured":"Settle EC Jr (1995) Valproic acid-associated encephalopathy with coma. Am J Psychiatry 152(8):1236\u20131237","journal-title":"Am J Psychiatry"},{"key":"2150_CR42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004850-200501000-00012","volume":"20","author":"RJ Kimmel","year":"2005","unstructured":"Kimmel RJ, Irwin SA, Meyer JM (2005) Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting. Int Clin Psychopharmacol 20:57\u201358","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"2150_CR43","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/appi.ajp.164.7.1020","volume":"164","author":"RB Carr","year":"2007","unstructured":"Carr RB, Shrewsbury K (2007) Hyperammonemia due to valproic acid in the psychiatric setting. Am J Psychiatry 164(7):1020\u20131027","journal-title":"Am J Psychiatry"},{"issue":"1","key":"2150_CR44","first-page":"84","volume":"33","author":"CC Hung","year":"2011","unstructured":"Hung CC, Li TM, Wei IH, Huang CC (2011) The real mechanism of VPA-induced hyperammonemia remains unknown. Gen Hosp Psychiatr 33(1):84, e3-4","journal-title":"Gen Hosp Psychiatr"},{"key":"2150_CR45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.pnpbp.2004.05.041","volume":"28","author":"A Reif","year":"2004","unstructured":"Reif A, Leonhard C, Mobner R, Lesch KP, Fallgatter AJ (2004) Encephalopathy and myoclonus triggered by valproic acid. Prog Neuropsychopharmacol Biol Psychiatr 28:1061\u20131063","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"2150_CR46","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1532-5415.2005.53338_7.x","volume":"53","author":"JT Stewart","year":"2005","unstructured":"Stewart JT (2005) Treatment of valproate-induced hyperammonemia. J Am Geriatr Soc 53:1080","journal-title":"J Am Geriatr Soc"},{"key":"2150_CR47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pnpbp.2010.02.017","volume":"34","author":"CL Khoo","year":"2010","unstructured":"Khoo CL, Naik S, Lua R, Chai SB, Liew A, Sim K (2010) Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature. Prog Neuropsychpharmacol Biol Psychiatr 34:561\u2013562","journal-title":"Prog Neuropsychpharmacol Biol Psychiatr"},{"key":"2150_CR48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/00952991003674804","volume":"36","author":"J Starer","year":"2010","unstructured":"Starer J, Chang G (2010) Hyperammoneic encephalopathy, valproic acid, and benzodiazepine withdrawal: a case series. Am J Drug Alcohol Abuse 36:98\u2013101","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2150_CR49","doi-asserted-by":"crossref","first-page":"802121","DOI":"10.1155\/2009\/802121","volume":"2009","author":"V Mittal","year":"2009","unstructured":"Mittal V, Muralee S, Tampi RR (2009) Valproic acid-induced hyperammonemia in the elderly: a review of the literature. Case Report Med 2009:802121","journal-title":"Case Report Med"},{"issue":"1","key":"2150_CR50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/0897190007303054","volume":"20","author":"CA Ott","year":"2007","unstructured":"Ott CA, Campbell N, Dworek EA (2007) Valproic acid-induced hyperammonaemia in a patient with schizoaffective disorder. J Pharm Prac 20(1):82\u201392","journal-title":"J Pharm Prac"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2150-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2150-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2150-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T16:16:31Z","timestamp":1562516191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2150-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,28]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2150"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2150-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,28]]}}}